Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target

M Zhang, C Liu, Y Li, H Li, W Zhang, J Liu… - Frontiers in cell and …, 2024 - frontiersin.org
Galectin-9 (Gal-9) is a vital member of the galectin family, functioning as a multi-subtype
galactose lectin with diverse biological roles. Recent research has revealed that Gal-9's …

Applications of machine learning in tumor-associated macrophages

Z Li, Q Yu, Q Zhu, X Yang, Z Li, J Fu - Frontiers in immunology, 2022 - frontiersin.org
Evaluation of tumor-host interaction and intratumoral heterogeneity in the tumor
microenvironment (TME) is gaining increasing attention in modern cancer therapies …

Treatment of multiple primary malignancies with PD-1 inhibitor camrelizumab: a case report and brief literature review

Y Wan, Z Wang, N Yang, F Liu - Frontiers in Oncology, 2022 - frontiersin.org
Background With significant advances in the diagnostic tools and treatment modalities of
cancer, the incidence of multiple primary malignancies (MPMs) has increased in the last …

[HTML][HTML] Blood Microbiota and Its Products: Mechanisms of Interference with Host Cells and Clinical Outcomes

L Santacroce, IA Charitos, M Colella… - Hematology …, 2024 - pmc.ncbi.nlm.nih.gov
In healthy conditions, blood was considered a sterile environment until the development of
new analytical approaches that allowed for the detection of circulating bacterial ribosomal …

[HTML][HTML] Integrated pathological analysis to develop a Gal-9 based immune survival stratification to predict the outcome of lung large cell neuroendocrine carcinoma …

Y Che, Z Luo, Y Cao, J Wang, Q Xue… - International Journal of …, 2022 - ncbi.nlm.nih.gov
Integrated pathological analysis to develop a Gal-9 based immune survival stratification to
predict the outcome of lung large cell neuroendocrine carcinoma and its usefulness in …

[HTML][HTML] Prognostic Value of 18F-FDG PET/CT Radiomics in Extranodal Nasal-Type NK/T Cell Lymphoma

Y Luo, Z Huang, Z Gao, B Wang, Y Zhang… - Korean Journal of …, 2024 - ncbi.nlm.nih.gov
Objective To investigate the prognostic utility of radiomics features extracted from 18 F-
fluorodeoxyglucose (FDG) PET/CT combined with clinical factors and metabolic parameters …

Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and …

S Seth, R Chen, Y Liu, J Fujimoto, L Hong… - Cancer …, 2024 - Wiley Online Library
Background Pulmonary sarcomatoid carcinoma (PSC) is a rare and aggressive subtype of
non‐small cell lung cancer (NSCLC), characterized by the presence of epithelial and …

[PDF][PDF] Imaging features of intestinal metastasis from pulmonary sarcomatoid carcinoma

H Wu, T Tang, LB Yi - International Journal of Radiation Research, 2023 - sid.ir
Background: The aim of this study was to examine the imaging features of patients
diagnosed with pulmonary sarcoma (PSC) exhibiting small bowel metastases, utilizing …